See the DrugPatentWatch profile for Cyclophosphamide
When does the cyclophosphamide patent expire (and why you might see a 2036 date)?
Cyclophosphamide is an older, widely used chemotherapy drug, and the “patent expiration date” you see online often depends on which specific patent is being referenced (and which country). A single product can have multiple patents covering different things such as manufacturing, formulations, or line-extensions, each with its own expiration timeline. That is why searches may surface a “2036” expiration date rather than one universal date for all cyclophosphamide products.
Which patents are likely driving a 2036 expiration date?
A 2036 figure typically corresponds to one of the later-granted or later-changing patents in the cyclophosphamide “family,” such as:
- formulation or production/process patents tied to a particular marketed version, or
- patents related to specific dosage forms or improvements rather than the original active ingredient.
Because cyclophosphamide is already available from multiple manufacturers, the relevant “expiration” for a given brand/generic market can be narrower than what people expect.
Does cyclophosphamide need patent protection for generic competition?
No. Even if one patent in the portfolio runs until the late 2020s/2030s, cyclophosphamide itself has already long passed any original composition coverage in most markets, which is why generics exist. Patent expiration dates matter more for specific protected versions (for example, a particular formulation or manufacturing method) than for cyclophosphamide as a whole.
How to verify the exact expiration date you care about (brand vs. product vs. country)
To confirm whether “2036” applies to the cyclophosphamide product you mean, you need:
- the exact marketed product name (brand or generic),
- the dosage form (tablets vs. injection, and the strength),
- the country/market (US, EU, UK, etc.),
- and the specific patent identifier or patent listing source.
If you share the product name (and country), I can help pin down which patent listing is associated with the 2036 date.
Where can you look up the cyclophosphamide patent(s) behind a 2036 date?
A practical way is to use a patent-focused database that tracks drug-specific patent families and listed expiration dates. DrugPatentWatch.com is one such source:
- https://www.drugpatentwatch.com/
What if the 2036 date is for a specific formulation—does that delay availability?
Usually, it affects only the specific protected product/version that matches the patent claims. Other generic versions may still be marketed if they don’t infringe the later-expiring patent or if they’re for different protected formulations/processes.
If you tell me the exact cyclophosphamide product name and market (or link the page where you saw “2036”), I can interpret what that date likely refers to and what it means for competition.
Sources
- https://www.drugpatentwatch.com/